Alan Lenox‐Smith - Concepedia

Author

Alan Lenox‐Smith

Also Known As

A Lenox-Smith, A. J. Lenox-Smith, A. Lenox-Smith, A. Lenox‐Smith, A.J. Lenox-Smith, Alan J Lenox-Smith, Alan J. Lenox-Smith, Alan J. Lenox‐Smith, Alan Lenox-Smith, Alan Lenox‐Smith

Publications

642

Citations

H-Index

Concepts

All Affiliations

Eli Lilly (United Kingdom)Eli Lilly (Germany)Eli Lilly (United States)Huntercombe Hospital Eli Lilly (Spain)

About

Alan Lenox‐Smith is an author at Eli Lilly (United Kingdom) specializing in psychopathology, psychiatry, and medicine.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	7	7	151
2	Psychiatry	7	7	151
3	Social Sciences	6	6	119
4	Pharmacology	2	2	58
5	Psychology	2	2	32

Alan Lenox‐Smith

Publications

538

Citations

H-Index

Page 1

	Year	Citations
Venlafaxine extended release versus citalopram in patients with depression unresponsive to a selective serotonin reuptake inhibitor Alan Lenox‐Smith, Qin Jiang International Clinical Psychopharmacology	2008	63
A double-blind, randomised, placebo controlled study of venlafaxine XL in patients with generalised anxiety disorder in primary care. Alan Lenox‐Smith, Alan Reynolds PubMed	2003	58
Health care resource utilisation in primary care prior to and after a diagnosis of Alzheimer’s disease: a retrospective, matched case–control study in the United Kingdom Lei Chen, Catherine Reed, Michael Happich, BMC Geriatrics	2014	56
Efficacy and safety of duloxetine in the treatment of older adult patients with generalized anxiety disorder: a randomized, double‐blind, placebo‐controlled trial Karla Alaka, W. C. Noble, Ángel L. Montejo, International Journal of Geriatric Psychiatry	2014	44
Quality of Life in Depressed Patients in UK Primary Care: The FINDER Study Alan Lenox‐Smith, Mark T. B. Macdonald, Catherine Reed, Neurology and Therapy	2013	36
Are there different predictors of analgesic response between antidepressants and anticonvulsants in painful diabetic neuropathy? Paolo Marchettini, Stefan Wilhelm, Helmut Petto, European Journal of Pain	2015	33
Cost Effectiveness of Representatives of Three Classes of Antidepressants Used in Major Depression in the UK Alan Lenox‐Smith, Pete Conway, C Knight PharmacoEconomics PsychiatryHealth EconomicsPsychotropic MedicationMajor DepressionDepression	2004	32
Pharmacoeconomic Analysis of Antidepressants for Major Depressive Disorder in the United Kingdom Hugh Freeman, Steve Arikian, Alan Lenox‐Smith PharmacoEconomics Pharmacoeconomic AnalysisPsychiatryHealth EconomicsMedicinePsychotropic Medication	2000	30
Resource utilisation, costs and clinical outcomes in non-institutionalised patients with Alzheimer’s disease: 18-month UK results from the GERAS observational study Alan Lenox‐Smith, Catherine Reed, Jérémie Lebrec, BMC Geriatrics	2016	29
Impact of patient selection and study characteristics on signal detection in placebo-controlled trials with antidepressants Michele Mancini, Alan Wade, Giulio Perugi, Journal of Psychiatric Research Placebo ResponsePatient SelectionPsychotropic MedicationPsychopharmacologyPharmacotherapy	2014	28

Page 1